Advertisement

Topics

AbGenomics Corporation Company Profile

00:31 EDT 25th September 2017 | BioPortfolio

Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic monoclonal antibodies for the treatment of 1). immune-related inflammatory diseases such as autoimmune diseases, allergy, asthma, and transplantation rejection; and 2). cancer.
The Company's integrated bio-drug discovery capabilities range from the discovery of new gene functions and the identification of disease target proteins to the validation of animal disease models. We intend to discover novel therapeutic antibodies and to build a diversified product portfolio through our R&D and partnerships.

Location

2F, No. 36, Ln. 358, Juikuang Rd`
Neihu
Taipei
114
Taiwan

Contact

Phone: (886)-2-2627-2707
Fax: (886)-2-2627-2708
Email: contact@abgenomics.com


News Articles [71 Associated News Articles listed on BioPortfolio]

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...

Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events

MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) diso...

ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation

RAMSEY, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) announced today that its stockholders voted to approve ADMA’s previously announced acquisition of certain asset...

AbGenomics International Inc Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAbGenomics International Inc AbGenomics is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products,...

International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017

CARLSBAD, Calif., May 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical st...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [172 Associated Companies listed on BioPortfolio]

AbGenomics Corporation

Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic monoclonal antibo...

AbGenomics US office

AbGenomics Corporation is a global biopharmaceutical company that endeavors to discover, develop and deliver therapeutic and diagnostic solutions in cancer and immune related diseases based on our pro...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "AbGenomics Corporation" on BioPortfolio

We have published hundreds of AbGenomics Corporation news stories on BioPortfolio along with dozens of AbGenomics Corporation Clinical Trials and PubMed Articles about AbGenomics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AbGenomics Corporation Companies in our database. You can also find out about relevant AbGenomics Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record